AlphAIalphai — Financial news for AI agents
rttnews.comJUL 292 min read$BG

Bunge Global Raises 2026 Adj. EPS Outlook Range

Bunge Global SA (BG) raised its 2026 adjusted EPS outlook to $9.25 to $9.75 from $9.00 to $9.50, citing higher Soybean Processing and Refining and Softseed Processing and Refining, and lower Grain Merchandising and Milling. Q2 earnings were $678 million, or $3.47/share, versus $354 million, or $2.61/share a year earlier. Revenue rose 88.3% to $24.041 billion. Shares were up 1.29% pre-market at $118.88.

Original reporting
rttnews.com
Published Jul 29, 2026, 11:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 12:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Bunge Global Raises 2026 Adj. EPS Outlook Range — source image
Source · rttnews.com
Decision brief

The 30-second read

$BGBullishMed
01

Why it matters

A higher FY 2026 adjusted EPS range, alongside stronger Q2 per-share results, can prompt upward revisions to 2026 estimates and support momentum in the name.

02

Market read

Traders can reassess 2026 earnings expectations and positioning based on the guidance range increase and segment mix commentary.

03

What to watch

The article does not quantify drivers behind the segment changes, so traders may need to verify whether the higher range is durable versus one-off.

Relevance 8/10Novelty 7/10Timing: pre-market today after-hours guidance update for FY 2026

Background

Bunge Global provided an updated FY 2026 adjusted EPS range and referenced directional changes by business segment.

Company-level read

Ticker impact

$BGBullishMedium confidence
Context

Bunge Global raised its full-year 2026 adjusted EPS outlook to $9.25 to $9.75 from $9.00 to $9.50.

Expected impact

Likely supportive for the stock, especially if investors were positioned for flat or lower 2026 EPS.

Evidence & confidence

The article provides a concrete EPS range increase and ties it to directional segment expectations, which typically drives estimate revisions and sentiment.

Market effects

Sector

Signals improving profitability expectations in parts of the agri-processing/refining chain, with offsetting weakness in grain merchandising/milling.

Regional

Limited direct regional read-through; primarily affects US-listed agri-processing sentiment.

Global

Moderate, as global grain and oilseed processing margins can influence broader commodity-linked equities.

Counterpoint

What could challenge this read

The guidance raise may reflect mix and cost/volume assumptions that could reverse if commodity spreads or crush margins deteriorate.

Key entities

  • company
    Bunge Global SA

    Raised FY 2026 adjusted EPS outlook to $9.25 to $9.75 and reported Q2 earnings and revenue growth.

Read at source← All news

Related articles

AUG 5
$BGMed

Why is Bunge stock rallying today?

Investing.com reports Bunge shares rose about 3.7% after its Q2 2026 results (released July 29). Adjusted EPS was $2.00 vs ~$1.95 expected, and revenue was $24.04B vs expectations. The stock had fallen on concerns about Viterra integration and working capital. Analysts at Texas Capital and BMO reiterated Buy, with a $150 target, and an Aug. 18 ex-dividend date for a $0.72 quarterly payment.

investing.com3 min
JUL 30
$BGMedAI 8/10

PTSB acquisition: Shareholders approve transaction

Permanent TSB (PTSB) shareholders approved BAWAG Group’s all-cash offer to buy 100% of PTSB’s issued share capital. The scheme meeting vote backed the transaction with 91% of votes cast, and related resolutions at the EGM received required approvals. Completion is expected in Q4 2026 or Q1 2027, pending court sanction and remaining regulatory approvals.

investegate.co.uk3 min
JUL 29
$BGMed

Bunge Global (NYSE:BG) Beats Q2 CY2026 Sales Expectations

Bunge Global (NYSE:BG) reported Q2 CY2026 results, with sales rising 88.3% year on year to $24.04 billion, topping Wall Street’s revenue estimate by 9.3%, according to the company. Non-GAAP profit was $2 per share, 2.9% above consensus. The article also cites Q2 cash burn of $1.03 billion and notes the stock was about $117.50 after results.

financialcontent.com4 min
JUL 29
$BGMedAI 8/10

Bunge beats second-quarter profit estimates on strong processing margins By Reuters

Reuters reports Bunge beat Wall Street’s Q2 profit estimates, citing strong soybean and softseed processing margins. The company raised its 2026 adjusted earnings forecast to $9.25 to $9.75 per share. Soybean processing and refining net sales were $12.07 billion, and softseed net sales were $4.09 billion. Reuters links improved demand to higher U.S. corn and soybean prices.

investing.com3 min
JUL 29
$BGMed

Bunge Global SA (BG): Results of Operations and Financial Condition

Bunge Global SA (BG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 epr06302026.htm EX-99.1 Document Bunge Reports Second Quarter 2026 Results St. Louis, MO - July 29, 2026 - Bunge Global SA (NYSE: BG) today reported second quarter 2026 results • Q2 GAAP diluted EPS of $3.47 vs. $2.61 in the prior year; $2.00 vs. $1.31 on an adjusted ba

SEC EDGAR 8-K6 min
AUG 8
$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

yahoo.com6 min